Literature DB >> 57904

Detection of HBSAG in fixed liver tissue - use of a modified immunofluorescent technique and comparison with histochemical methods.

B Portmann, R M Galbraith, A L Eddleston, A J Zuckerman, R Williams.   

Abstract

A modified immunofluorescent technique was used for the detection of HBSAg in formalin-fixed liver tissue, thereby allowing retrospective examination of paraffin sections and avoiding the need to split the sample at the time of biopsy. Comparison with two other methods, involving either orcein staining or standard haematoxylin and eosin (H and E) preparation for ground glass hepatocytes, showed slightly fewer positive hepatocytes in individual biopsies with the latter stain, but the specificity of both methods was high. In a series of 146 seropositive and 74 seronegative patients with a variety of liver disorders, hepatocytes positive for HBSAg were found in only one of 55 patients with acute hepatitis type B, whereas large numbers of positive cells were seen in all 22 healthy carriers of the surface antigen. In the 69 patients with chronic persistent or chronic aggressive hepatitis, the frequency of positive biopsies was 86% and 85% respectively. The positive cells in these cases were, in comparison with healthy carriers of HBSAg, much fewer in number and were scattered in random fashion throughout the lobule rather than occurring in discrete clumps or sheets. This variation in the intrahepatic expression of HBSAg may reflect differences in the immune response to hepatitis B viral antigens.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 57904      PMCID: PMC1411055          DOI: 10.1136/gut.17.1.1

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  Immunoperoxidase localisation of hepatitis B antigen (HB) in formalin-paraffin processed liver tissue.

Authors:  J Burns
Journal:  Histochemistry       Date:  1975-07-30

2.  Electron microscopy of serum of healthy hepatitis B antigen carriers.

Authors:  I L Woolf; D M Jones; E Tapp; I W Dymock
Journal:  J Clin Pathol       Date:  1975-04       Impact factor: 3.411

3.  Cellular and humoral immunity to hepatitis-B surface antigen in active chronic hepatitis.

Authors:  W M Lee; W D Reed; C G Mitchell; R M Galbraith; A L Eddleston; A J Zuckerman; R Williams
Journal:  Br Med J       Date:  1975-03-29

4.  Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers.

Authors:  S Hadziyannis; M A Gerber; C Vissoulis; H Popper
Journal:  Arch Pathol       Date:  1973-11

5.  Staining methods of Australia antigen in paraffin section--detection of cytoplasmic inclusion bodies.

Authors:  T Shikata; T Uzawa; N Yoshiwara; T Akatsuka; S Yamazaki
Journal:  Jpn J Exp Med       Date:  1974-02

6.  Australia antigen in liver tissue--an immunofluorescent and immunoelectron microscopic study.

Authors:  T Shikata
Journal:  Jpn J Exp Med       Date:  1973-08

7.  Investigations of liver biopsies for Australia antigen by immunofluorescent technique.

Authors:  J O Nielsen; P Elling
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

8.  Cytoplasmic localisation of Australia antigen in the liver.

Authors:  S Hadziyannis; A Moussouros; C Vissoulis; A Afroudakis
Journal:  Lancet       Date:  1972-05-06       Impact factor: 79.321

9.  Pattern of core and surface expression in liver tissue reflects state of specific immune response in hepatitis B.

Authors:  F Gudat; L Bianchi; W Sonnabend; G Thiel; W Aenishaenslin; G A Stalder
Journal:  Lab Invest       Date:  1975-01       Impact factor: 5.662

10.  Cell-mediated immunity to hepatitis B surface antigen in blood donors with persistent antigenaemia.

Authors:  W M Lee; W D Reed; C G Mitchell; I L Woolf; I W Dymock; A L Eddleston; R Williams
Journal:  Gut       Date:  1975-06       Impact factor: 23.059

View more
  19 in total

1.  Immunohistochemical patterns of hepatitis B surface antigen (HBsAg) in patients with hepatitis, renal homografts recipients and normal carriers.

Authors:  J P Camilleri; C Amat; M Chousterman; J P Petite; A Duboust; A Boddaert; A Paraf
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-12-08

2.  Detection of HBsAg containing cells in liver biopsies by different stains and classification of positively reacting ground-glass hepatocytes.

Authors:  F Borchard; V Gussmann
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-10

3.  T lymphocyte-mediated cytotoxicity in HBsAg-positive liver disease.

Authors:  N El Sheikh; C G Osman; H Cullens; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

4.  Hepatitis B virus antigens in primary hepatic carcinoma: immunofluorescent techniques on fixed liver tissue.

Authors:  A Trevisan; G Realdi; C Losi; V Ninfo; M Rugge; L Rampinelli
Journal:  J Clin Pathol       Date:  1978-12       Impact factor: 3.411

5.  The role of the pathologist in environmental medicine and public health.

Authors:  J Higginson
Journal:  Am J Pathol       Date:  1977-02       Impact factor: 4.307

6.  Repeated application of first-layer antiserum improves immunofluorescence staining: a modification of the indirect immunofluorescence staining procedure.

Authors:  J Gu; K N Islam; J M Polak
Journal:  Histochem J       Date:  1983-05

7.  Value of copper-associated protein in diagnostic assessment of liver biopsy.

Authors:  P Guarascio; F Yentis; U Cevikbas; B Portmann; R Williams
Journal:  J Clin Pathol       Date:  1983-01       Impact factor: 3.411

8.  HBsAg and HBcAg in the livers of asymptomatic hepatitis B antigen carriers.

Authors:  E Tapp; D M Jones
Journal:  J Clin Pathol       Date:  1977-07       Impact factor: 3.411

9.  Methods for detection of hepatitis B surface antigen in paraffin sections of liver: a guideline for their use.

Authors:  E Sumithran
Journal:  J Clin Pathol       Date:  1977-05       Impact factor: 3.411

10.  Aetiology of cirrhosis, hepatic fibrosis, and hepatocellular carcinoma.

Authors:  W K Blenkinsopp; G P Haffenden
Journal:  J Clin Pathol       Date:  1977-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.